Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Treasury Shares (2016 - 2024)

Historic Treasury Shares for Usana Health Sciences (USNA) over the last 9 years, with Q4 2024 value amounting to $592000.0.

  • Usana Health Sciences' Treasury Shares rose 2081.63% to $592000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $592000.0, marking a year-over-year increase of 2081.63%. This contributed to the annual value of $592000.0 for FY2024, which is 2081.63% up from last year.
  • As of Q4 2024, Usana Health Sciences' Treasury Shares stood at $592000.0, which was up 2081.63% from $490000.0 recorded in Q4 2023.
  • Usana Health Sciences' Treasury Shares' 5-year high stood at $592000.0 during Q4 2024, with a 5-year trough of $323000.0 in Q1 2021.
  • Its 4-year average for Treasury Shares is $431200.0, with a median of $385000.0 in 2022.
  • As far as peak fluctuations go, Usana Health Sciences' Treasury Shares skyrocketed by 519.13% in 2022, and later surged by 2727.27% in 2023.
  • Usana Health Sciences' Treasury Shares (Quarter) stood at $323000.0 in 2021, then rose by 19.2% to $385000.0 in 2022, then rose by 27.27% to $490000.0 in 2023, then rose by 20.82% to $592000.0 in 2024.
  • Its last three reported values are $592000.0 in Q4 2024, $490000.0 for Q4 2023, and $385000.0 during Q4 2022.